Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme 10 selected

Guidance programme

Showing 871 to 880 of 1174

TitleReference numberPublishedLast updated
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Hypothermia: prevention and management in adults having surgeryCG65
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420

Results per page

  1. 10
  2. 25
  3. 50
  4. All